194 related articles for article (PubMed ID: 31823782)
21. MicroRNA-1270 modulates papillary thyroid cancer cell development by regulating SCAI.
Yi T; Zhou X; Sang K; Zhou J; Ge L
Biomed Pharmacother; 2019 Jan; 109():2357-2364. PubMed ID: 30551495
[TBL] [Abstract][Full Text] [Related]
22. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway.
Lv P; Xue Y
Bioengineered; 2021 Dec; 12(1):3873-3885. PubMed ID: 34281460
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic targeting of TNIK in papillary thyroid carcinoma: a novel approach for tumor growth suppression.
Zhang R; Yu Y; Yang Y; Zhang M; Zhang X; Chang Y; Wang S; Hu L; Li J; Zheng X; Zhao R; Guo Y; Ni X
Med Oncol; 2024 May; 41(6):160. PubMed ID: 38763968
[TBL] [Abstract][Full Text] [Related]
24. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.
Qiu W; Yang Z; Fan Y; Zheng Q
Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298
[TBL] [Abstract][Full Text] [Related]
25. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
26. PDLIM7 Promotes Tumor Metastasis in Papillary Thyroid Carcinoma via Stabilizing Focal Adhesion Kinase Protein.
Yang F; Yang M; Liu Y; Zhou C; Chen Y; Wu J; Zhang X; Xiao S
Thyroid; 2024 May; 34(5):598-610. PubMed ID: 38243825
[No Abstract] [Full Text] [Related]
27. IL-34 is a potential biomarker for the treatment of papillary thyroid cancer.
Zhang P; Zhang H; Dong W; Wang Z; Qin Y; Wu C; Dong Q
J Clin Lab Anal; 2020 Aug; 34(8):e23335. PubMed ID: 32573824
[TBL] [Abstract][Full Text] [Related]
28. Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling.
Zhu J; Li X; Zhang S; Liu J; Yao X; Zhao Q; Kou B; Han P; Wang X; Bai Y; Zheng Z; Xu C
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S87-S95. PubMed ID: 34219514
[TBL] [Abstract][Full Text] [Related]
29. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway.
Zhong J; Lin R; Wang G; Lin L; Ruan S; Liu W
Tissue Cell; 2022 Apr; 75():101739. PubMed ID: 35066335
[TBL] [Abstract][Full Text] [Related]
30. FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway.
Zhao C; Mo L; Li C; Han S; Zhao W; Liu L
Mol Cell Endocrinol; 2020 Sep; 515():110925. PubMed ID: 32619584
[TBL] [Abstract][Full Text] [Related]
31. Cep63 knockout inhibits the malignant phenotypes of papillary thyroid cancer cell line TPC‑1.
Liu C; Yu F; Ma R; Zhang L; Du G; Niu D; Yin D
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296302
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA SAMMSON promotes papillary thyroid carcinoma progression through p300/Sp1 axis and serves as a novel diagnostic and prognostic biomarker.
Shao L; Sun W; Wang Z; Dong W; Qin Y
IUBMB Life; 2020 Feb; 72(2):237-246. PubMed ID: 31478331
[TBL] [Abstract][Full Text] [Related]
33. SHCBP1 Promotes Papillary Thyroid Carcinoma Carcinogenesis and Progression Through Promoting Formation of Integrin and Collagen and Maintaining Cell Stemness.
Geng H; Guo M; Xu W; Zang X; Wu T; Teng F; Wang Y; Liu X; Wang X; Sun Q; Liang J
Front Endocrinol (Lausanne); 2020; 11():613879. PubMed ID: 33716952
[TBL] [Abstract][Full Text] [Related]
34. miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1.
Ma S; Jia W; Ni S
Biochem Biophys Res Commun; 2018 Feb; 497(1):181-186. PubMed ID: 29427661
[TBL] [Abstract][Full Text] [Related]
35. The role of Slit2 as a tumor suppressor in thyroid cancer.
Jeon MJ; Lim S; You MH; Park Y; Song DE; Sim S; Kim TY; Shong YK; Kim WB; Kim WG
Mol Cell Endocrinol; 2019 Mar; 483():87-96. PubMed ID: 30648543
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of RET gene mediated EGFR signaling pathway on epithelial-mesenchymal transition, proliferation and apoptosis of papillary thyroid carcinoma cells.
Zhao YL; Yuan BQ; Shen GS
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8036-8047. PubMed ID: 32767330
[TBL] [Abstract][Full Text] [Related]
37. CircRNA circ-ITCH suppresses papillary thyroid cancer progression through miR-22-3p/CBL/β-catenin pathway.
Wang M; Chen B; Ru Z; Cong L
Biochem Biophys Res Commun; 2018 Sep; 504(1):283-288. PubMed ID: 30190130
[TBL] [Abstract][Full Text] [Related]
38. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
[TBL] [Abstract][Full Text] [Related]
39. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.
Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J
Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202
[TBL] [Abstract][Full Text] [Related]
40. DNA copy number gain-mediated lncRNA LINC01061 upregulation predicts poor prognosis and promotes papillary thyroid cancer progression.
Wu X; Yan Y; Li H; Ji N; Yu T; Huang Y; Shi W; Gao L; Ma L; Hu Y
Biochem Biophys Res Commun; 2018 Sep; 503(3):1247-1253. PubMed ID: 30029886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
